NI — NiSource Inc

The market tone is cautious: the stock is down 9.2% from its 200-day average and near oversold, while Indiana's IURC investigation into multi-year rate plans, allowed ROEs, and cost-recovery trackers is creating regulatory overhang. Mizuho and BMO recently trimmed price targets, and Q2 GAAP net income fell roughly 55% year over year. Wall Street still has a Buy consensus, but near-term sentiment is clearly defensive.

Revenue growth was strong through 2025—Q2, Q3, and Q4 2025 were all up 18-20% year over year—then decelerated to +8.2% in Q1 2026 and +4.6% in Q2 2026. Q2 2026 operating margin compressed to 17.0% from 20.5% a year earlier, and net margin fell to 3.4% from 8.0%, driven by higher O&M, unseasonal weather, and union-related costs. Because Q1 is the high-margin winter quarter for a gas utility and management reaffirmed FY2026 EPS guidance, this looks like a temporary blip rather than a structural break, but Q3/Q4 need to confirm.

The trailing P/E of 21.6 is distorted by the weak Q2; on FY2026 adjusted EPS of $2.056, the forward P/E is roughly 19.9, slightly above NiSource's 5-year average of 19.18. Price-to-sales of 2.85 is above the 5-year average of 2.43, and price-to-book of 2.05 is not cheap for a utility. The 2.66% dividend yield is acceptable but not high. Overall, valuation looks fair to slightly rich—not a distressed bargain.

At $40.96, the market is paying about 19.9x forward EPS and is not crediting much of the company's stated 9-10% long-term EPS CAGR. The stock has de-rated despite reaffirmed guidance, so the price is embedding a regulatory discount rather than a growth premium. If IURC issues resolve constructively, re-rating toward the analyst consensus target of ~$50.71 is plausible; if the regulatory picture worsens, the stock could test the 52-week low near $38.45.

As of 2026-08-27, RSI stood at 31.82, near oversold. The stock was 3.03% below its 20-day, 8.88% below its 50-day, and 9.23% below its 200-day moving average—consistent with a short- and intermediate-term downtrend. A technical bounce is possible from oversold conditions, but the prudent entry trigger would be stabilization above the 20-day (~$42.24) or a successful hold of the $38.45 support area.

• Utility valuations are highly sensitive to Treasury yields; rising rates pressure the stock despite its low 0.55 beta.
• Indiana IURC's broad regulatory investigation into multi-year rate plans, ROEs, and cost-recovery trackers creates rate-setting uncertainty.
• Hyperscale data center load growth in Indiana (3 GW active negotiations, 2 GW line of sight) is a big capital investment opportunity but draws regulatory scrutiny over cost-sharing and infrastructure burden.
• Weather normalization matters: unseasonal mild weather reduced Q2 gas demand and contributed to the earnings miss.
• Defensive sector rotation: NiSource's 2.66% dividend and regulated cash flows attract risk-off flows but lag in risk-on markets.

• IURC proceedings/determinations on multi-year rate plans and authorized ROEs—a constructive outcome could remove the overhang.
• Q3 2026 earnings in early November, which will show whether back-half-weighted adjusted EPS growth is on track.
• Additional data center / large-load agreements with tech tenants like Alphabet and Amazon, supporting the multi-gigawatt pipeline.
• Dividend calendar: ex-dividend date October 30, 2026, with payment November 20, 2026.
• Resolution of ongoing union negotiations would reduce workforce continuity cost pressure.

• Regulatory disallowances, lower authorized ROE, or changes to cost-recovery mechanisms in Indiana/Ohio.
• High leverage (debt-to-equity ~1.84) combined with persistently negative free cash flow increases sensitivity to rising debt costs.
• O&M cost inflation and labor-related disruptions could keep compressing margins.
• Mild winter weather or below-normal heating demand could pressure future quarters.

NiSource has a credible long-term growth story—regulated gas distribution, a data-center-driven pipeline, and 9-10% EPS CAGR through 2033—but the stock is not priced at a distressed level and the market is actively flagging regulatory risk. I view it as a balanced hold right now: not a compelling buy until the IURC overhang clears or the chart establishes a firmer bottom, and not a sell given the growth and dividend support.

I used a simplified two-stage dividend discount model: current annual dividend of $1.20, 8% dividend growth for 5 years, 5% terminal growth, and 8.5% cost of equity, which gives $41.10. Cross-checking with 20x FY2026 adjusted EPS of $2.056 also yields ~$41.12, so fair value is very close to the current market price.